1. Home
  2. PT vs TXMD Comparison

PT vs TXMD Comparison

Compare PT & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • TXMD
  • Stock Information
  • Founded
  • PT 2012
  • TXMD 2008
  • Country
  • PT China
  • TXMD United States
  • Employees
  • PT N/A
  • TXMD N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • TXMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PT Technology
  • TXMD Health Care
  • Exchange
  • PT Nasdaq
  • TXMD Nasdaq
  • Market Cap
  • PT 15.2M
  • TXMD 17.1M
  • IPO Year
  • PT 2018
  • TXMD N/A
  • Fundamental
  • Price
  • PT $0.90
  • TXMD $1.18
  • Analyst Decision
  • PT
  • TXMD
  • Analyst Count
  • PT 0
  • TXMD 0
  • Target Price
  • PT N/A
  • TXMD N/A
  • AVG Volume (30 Days)
  • PT 15.7K
  • TXMD 69.5K
  • Earning Date
  • PT 07-07-2025
  • TXMD 08-11-2025
  • Dividend Yield
  • PT N/A
  • TXMD N/A
  • EPS Growth
  • PT N/A
  • TXMD N/A
  • EPS
  • PT N/A
  • TXMD N/A
  • Revenue
  • PT $4,814,566.00
  • TXMD $1,841,000.00
  • Revenue This Year
  • PT N/A
  • TXMD $427.09
  • Revenue Next Year
  • PT N/A
  • TXMD N/A
  • P/E Ratio
  • PT N/A
  • TXMD N/A
  • Revenue Growth
  • PT N/A
  • TXMD 53.55
  • 52 Week Low
  • PT $0.76
  • TXMD $0.70
  • 52 Week High
  • PT $1.15
  • TXMD $2.44
  • Technical
  • Relative Strength Index (RSI)
  • PT 46.18
  • TXMD 47.25
  • Support Level
  • PT $0.82
  • TXMD $1.11
  • Resistance Level
  • PT $0.94
  • TXMD $1.22
  • Average True Range (ATR)
  • PT 0.06
  • TXMD 0.09
  • MACD
  • PT 0.00
  • TXMD 0.00
  • Stochastic Oscillator
  • PT 57.14
  • TXMD 42.31

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: